First clinical assessment of [18F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood

First clinical assessment of [18F]MC225, a novel fluorine-18 labelled PET tracer for measuring functional P-glycoprotein at the blood–brain barrier

Published:2021-08-08 Issue:11 Volume:35 Page:1240-1252
ISSN:0914-7187
Container-title:Annals of Nuclear Medicine
language:en
Short-container-title:Ann Nucl Med

Author:

Toyohara Jun^ORCID,Sakata Muneyuki,Ishibashi Kenji,Mossel Pascalle,Imai Masamichi,Wagatsuma Kei,Tago Tetsuro,Imabayashi Etsuko,Colabufo Nicola A.,Luurtsema Gert,Ishii Kenji

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12149-021-01666-9.pdf

Reference60 articles.

1. Terasaki T, Ohtsuki S. Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology, and methodology. NeuroRx. 2005;2:63–72.

2. Giacomini KM, Huang S-M. Transporters in drug development and clinical pharmacology. Clin Pharmacol Ther. 2013;94:3–9.

3. Graff CL, Pollack GM. Drug transporter at the blood–brain barrier and the choroid plexus. Curr Drug Metab. 2004;5:95–108.

4. Löscher W, Potschka H. Drug resistance in brain disease and the role of drug efflux transporters. Nat Rev Neurosci. 2005;6:591–602.

5. Feldmann M, Koepp M. ABC transporter and drug resistance in patients with epilepsy. Curr Pharm Des. 2016;22:5793–807.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET;European Journal of Nuclear Medicine and Molecular Imaging;2023-08-08